JP2007521333A5 - - Google Patents

Download PDF

Info

Publication number
JP2007521333A5
JP2007521333A5 JP2006545433A JP2006545433A JP2007521333A5 JP 2007521333 A5 JP2007521333 A5 JP 2007521333A5 JP 2006545433 A JP2006545433 A JP 2006545433A JP 2006545433 A JP2006545433 A JP 2006545433A JP 2007521333 A5 JP2007521333 A5 JP 2007521333A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
agonist
composition according
disorder
signaling pathway
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2006545433A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007521333A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/042271 external-priority patent/WO2005061002A2/en
Publication of JP2007521333A publication Critical patent/JP2007521333A/ja
Publication of JP2007521333A5 publication Critical patent/JP2007521333A5/ja
Withdrawn legal-status Critical Current

Links

JP2006545433A 2003-12-19 2004-12-15 中枢神経系の活動を調節するための組成物および方法 Withdrawn JP2007521333A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US53120103P 2003-12-19 2003-12-19
PCT/US2004/042271 WO2005061002A2 (en) 2003-12-19 2004-12-15 Composition and methods for modulating cns activity

Publications (2)

Publication Number Publication Date
JP2007521333A JP2007521333A (ja) 2007-08-02
JP2007521333A5 true JP2007521333A5 (https=) 2008-01-17

Family

ID=34710209

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006545433A Withdrawn JP2007521333A (ja) 2003-12-19 2004-12-15 中枢神経系の活動を調節するための組成物および方法

Country Status (9)

Country Link
US (1) US20050203014A1 (https=)
EP (1) EP1694353A2 (https=)
JP (1) JP2007521333A (https=)
CN (1) CN1917897A (https=)
AU (1) AU2004305582A1 (https=)
BR (1) BRPI0417491A (https=)
CA (1) CA2547338A1 (https=)
MX (1) MXPA06006659A (https=)
WO (1) WO2005061002A2 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7390659B2 (en) 2002-07-16 2008-06-24 The Trustees Of Columbia University In The City Of New York Methods for inducing differentiation of embryonic stem cells and uses thereof
US20040224302A1 (en) * 2002-07-16 2004-11-11 Thomas Jessel Systems and methods for screening for modulators of neural differentiation
US7632679B2 (en) * 2002-07-16 2009-12-15 The Trustees Of Columbia University In The City Of New York Systems and methods for screening for modulators of neural differentiation
WO2007028770A1 (en) * 2005-09-05 2007-03-15 Neurosearch A/S Monoamine neurotransmitter re-uptake inhibitors for neuroprotection in patients suffering from an advanced stage of a mental disease
WO2008020864A2 (en) * 2005-11-14 2008-02-21 The Trustees Of Columbia University In The City Of New York Imaging correlates of neurogenesis with mri
WO2008127974A1 (en) * 2007-04-13 2008-10-23 The Trustees Of Columbia University In The City Of New York Stem cell-based culture system for drug development
US8969081B2 (en) * 2008-12-10 2015-03-03 The Trustees Of Columbia University In The City Of New York Caudal motor neuron derived from embryonic stem cells under conditions essentially free of any retinoid
FR2966733B1 (fr) * 2010-10-29 2012-12-14 Centre Nat Rech Scient Nouvelles strategies therapeutiques impliquant la voie de signalisation hedgehog
CN104740633A (zh) * 2013-12-26 2015-07-01 中国科学院上海生命科学研究院 Shh信号通路特异性抑制剂的应用
JP6193176B2 (ja) * 2014-05-12 2017-09-06 ライオン株式会社 活力及び／又は集中力向上剤
CN111551729B (zh) * 2020-04-27 2021-02-09 浙江正熙生物技术股份有限公司 藻红蛋白免疫荧光探针制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6610656B1 (en) * 1993-12-30 2003-08-26 President And Fellows Of Harvard College Method of promoting chondrocyte differentiation with hedgehog related polypeptides
US5789543A (en) * 1993-12-30 1998-08-04 President And Fellows Of Harvard College Vertebrate embryonic pattern-inducing proteins and uses related thereto
US6165747A (en) * 1993-12-30 2000-12-26 President & Fellows Of Harvard College Nucleic acids encoding hedgehog proteins
US6261786B1 (en) * 1993-12-30 2001-07-17 Imperial Cancer Res. Technology Screening assays for hedgehog agonists and antagonists
US6271363B1 (en) * 1993-12-30 2001-08-07 President & Fellows Of Harvard College Nucleic acids encoding hedgehog proteins
US6027882A (en) * 1994-10-07 2000-02-22 The Regents Of The University Of California Patched genes and their use for diagnostics
US6429354B1 (en) * 1994-10-07 2002-08-06 The Board Of Trustees Of The Leland Stanford Junior University Patched genes and uses related thereto
AU4001195A (en) * 1994-10-07 1996-05-02 Board Of Trustees Of The Leland Stanford Junior University Patched genes and their use
US7144997B2 (en) * 1997-07-24 2006-12-05 Curis, Inc. Vertebrate embryonic patterning-inducing proteins, compositions and uses related therto
US6897297B1 (en) * 1997-12-03 2005-05-24 Curis, Inc. Hydrophobically-modified protein compositions and methods
IL143403A0 (en) * 1998-12-03 2002-04-21 Biogen Inc Methods and compositions for treating disorders involving excitotoxicity
EP1743903A2 (en) * 1998-12-03 2007-01-17 Curis, Inc. Methods and compositions for treating disorders involving excitotoxicity
WO2001046227A2 (en) * 1999-12-21 2001-06-28 University Of Zurich 'dispatched' polypeptides
US6683192B2 (en) * 2000-03-30 2004-01-27 Curis, Inc. Small organic molecule regulators of cell proliferation
WO2001082946A2 (en) * 2000-04-28 2001-11-08 Curis, Inc. Neuroprotective compositions
JP2004518654A (ja) * 2000-12-21 2004-06-24 ザ マクレーン ホスピタル コーポレーション 鬱病の治療法
US20060078499A1 (en) * 2003-12-01 2006-04-13 Rene Hen Use of hedgehog agonist to treat depression

Similar Documents

Publication Publication Date Title
Kato et al. Effects of the serotonin type 2A, 3A and 3B receptor and the serotonin transporter genes on paroxetine and fluvoxamine efficacy and adverse drug reactions in depressed Japanese patients
JP5775303B2 (ja) 不安に対する治療法
Xu et al. Role of microglia in methamphetamine-induced neurotoxicity
US20110059947A1 (en) Alpha 7 nicotinic agonists and antipsychotics
WO2020067575A1 (en) Gip receptor agonist peptide compounds and uses thereof
JP2007521333A5 (https=)
Singh et al. Pramipexole, ropinirole, and mania in Parkinson’s disease
Jia et al. Neuroprotective effects of chaperone-mediated autophagy in neurodegenerative diseases
JP2014523871A5 (https=)
JP2015522264A5 (https=)
JP6640725B2 (ja) ｓｐａｄｉｎのレトロ−インベルソ類似体は増大された抗うつ作用を示す
JP2006506942A5 (https=)
Lübke et al. Neurotrophic factors in Alzheimer’s disease: Pathogenesis and therapy
Zhang et al. A High MCT‐Based Ketogenic Diet Suppresses Th1 and Th17 Responses to Ameliorate Experimental Autoimmune Encephalomyelitis in Mice by Inhibiting GSDMD and JAK2‐STAT3/4 Pathways
JP2010532787A5 (https=)
Cheng et al. Different roles of astrocytes in the blood–brain barrier during the acute and recovery phases of stroke
JP2004532032A5 (https=)
WO2017070573A1 (en) Compositions and their use for controlling the nervous system in vivo
Lu et al. GluA1 degradation by autophagy contributes to circadian rhythm effects on cerebral ischemia injury
Scibelli et al. Dexmedetomidine: current role in burn ICU
JP2012524725A5 (https=)
CN103097404A (zh) 具有镇痛作用并抑制asic通道的新型肽
Ghali et al. Nafamostat mesylate attenuates the pathophysiologic sequelae of neurovascular ischemia
Kim et al. High mobility group box 1 in the central nervous system: regeneration hidden beneath inflammation
CN106565847B (zh) 化合物、多肽及其用途